Matinas BioPharma
MTNB
MTNB
18 hedge funds and large institutions have $1.97M invested in Matinas BioPharma in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
94% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 31
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$72.9K | |
| 2 | +$70.6K | |
| 3 | +$36.8K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$12.1K |
| 5 |
SA
Sanctuary Advisors
Indianapolis,
Indiana
|
+$6.04K |
Top Sellers
| 1 | -$299K | |
| 2 | -$299K | |
| 3 | -$297K | |
| 4 |
NRS
Neville Rodie & Shaw
New York
|
-$183K |
| 5 |
LPL Financial
San Diego,
California
|
-$96.9K |